Protein 1 | Protein 2 | Combine Score |
---|---|---|
SOD2 | CAT | 0.996 |
SOD2 | SOD1 | 0.996 |
SOD1 | CAT | 0.994 |
SOD2 | SOD3 | 0.993 |
SOD2 | GPX1 | 0.988 |
SOD3 | CAT | 0.988 |
GPX1 | GSR | 0.987 |
GPX1 | SOD1 | 0.986 |
GSR | GSS | 0.985 |
CAT | GSR | 0.977 |
GPX1 | SOD3 | 0.973 |
GPX1 | GSS | 0.954 |
GPX1 | ALOX5 | 0.919 |
SOD2 | GSR | 0.916 |
GPX1 | CAT | 0.915 |
SOD3 | SOD1 | 0.914 |
# | 6648 (SOD2) | 6647 (SOD1) | 6649 (SOD3) | 2876 (GPX1) | 2936 (GSR) | 847 (CAT) | 2937 (GSS) | 240 (ALOX5) |
---|---|---|---|---|---|---|---|---|
6648 (SOD2) | 1.00 | 0.75 | 0.79 | 0.44 | 0.31 | 0.56 | 0.63 | 0.66 |
6647 (SOD1) | 0.75 | 1.00 | 0.88 | 0.43 | 0.27 | 0.62 | 0.65 | 0.66 |
6649 (SOD3) | 0.79 | 0.88 | 1.00 | 0.43 | 0.29 | 0.52 | 0.55 | 0.68 |
2876 (GPX1) | 0.44 | 0.43 | 0.43 | 1.00 | 0.28 | 0.53 | 0.37 | 0.44 |
2936 (GSR) | 0.31 | 0.27 | 0.29 | 0.28 | 1.00 | 0.41 | 0.31 | 0.27 |
847 (CAT) | 0.56 | 0.62 | 0.52 | 0.53 | 0.41 | 1.00 | 0.58 | 0.52 |
2937 (GSS) | 0.63 | 0.65 | 0.55 | 0.37 | 0.31 | 0.58 | 1.00 | 0.55 |
240 (ALOX5) | 0.66 | 0.66 | 0.68 | 0.44 | 0.27 | 0.52 | 0.55 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GPX1 | Bird | Cardiac muscle | - | 4000 m | Native | downregulated | -4.83 | Sequencing | Central Asia | L. dichrous (Bird) | 1 | L. dichrous vs. Po. Palustris | 31127049 |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|---|---|---|---|---|---|---|---|
MIRT040633 | hsa-miR-92b-3p | Homo sapiens | GPX1 | 2876 | Homo sapiens | CLASH | Functional MTI (Weak) | 23622248 |
MIRT486917 | hsa-miR-4537 | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 26701625 |
MIRT486919 | hsa-miR-634 | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 23592263 |
MIRT486919 | hsa-miR-634 | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 26701625 |
MIRT486916 | hsa-miR-505-5p | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 26701625 |
MIRT486916 | hsa-miR-505-5p | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 23592263 |
MIRT486917 | hsa-miR-4537 | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 23592263 |
MIRT486918 | hsa-miR-1226-3p | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 26701625 |
MIRT486918 | hsa-miR-1226-3p | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 23592263 |
MIRT512626 | hsa-miR-4674 | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 23446348 |
MIRT512627 | hsa-miR-3147 | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 23446348 |
MIRT512630 | hsa-miR-4733-3p | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT512625 | hsa-miR-1587 | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT512626 | hsa-miR-4674 | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT512628 | hsa-miR-4437 | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 23446348 |
MIRT512624 | hsa-miR-3620-5p | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT512628 | hsa-miR-4437 | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT512631 | hsa-miR-1911-3p | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT512627 | hsa-miR-3147 | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT512625 | hsa-miR-1587 | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 23446348 |
MIRT512629 | hsa-miR-4259 | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 23446348 |
MIRT512630 | hsa-miR-4733-3p | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 23446348 |
MIRT512631 | hsa-miR-1911-3p | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 23446348 |
MIRT512624 | hsa-miR-3620-5p | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 23446348 |
MIRT512629 | hsa-miR-4259 | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT568883 | hsa-miR-4670-3p | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT568884 | hsa-miR-8060 | Homo sapiens | GPX1 | 2876 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
ID | GO ID | GO Term | GO Type |
---|---|---|---|
2876 | GO:0033599 | regulation of mammary gland epithelial cell proliferation | GOTERM_BP_DIRECT |
2876 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | GOTERM_BP_DIRECT |
2876 | GO:0009650 | UV protection | GOTERM_BP_DIRECT |
2876 | GO:0033194 | response to hydroperoxide | GOTERM_BP_DIRECT |
2876 | GO:0005829 | cytosol | GOTERM_CC_DIRECT |
2876 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | GOTERM_BP_DIRECT |
2876 | GO:0043523 | regulation of neuron apoptotic process | GOTERM_BP_DIRECT |
2876 | GO:0000302 | response to reactive oxygen species | GOTERM_BP_DIRECT |
2876 | GO:0001659 | temperature homeostasis | GOTERM_BP_DIRECT |
2876 | GO:0042311 | vasodilation | GOTERM_BP_DIRECT |
2876 | GO:0060055 | angiogenesis involved in wound healing | GOTERM_BP_DIRECT |
2876 | GO:0001885 | endothelial cell development | GOTERM_BP_DIRECT |
2876 | GO:0006195 | purine nucleotide catabolic process | GOTERM_BP_DIRECT |
2876 | GO:0017124 | SH3 domain binding | GOTERM_MF_DIRECT |
2876 | GO:0019372 | lipoxygenase pathway | GOTERM_BP_DIRECT |
2876 | GO:0061136 | regulation of proteasomal protein catabolic process | GOTERM_BP_DIRECT |
2876 | GO:0006641 | triglyceride metabolic process | GOTERM_BP_DIRECT |
2876 | GO:0018158 | protein oxidation | GOTERM_BP_DIRECT |
2876 | GO:0043403 | skeletal muscle tissue regeneration | GOTERM_BP_DIRECT |
2876 | GO:0070062 | extracellular exosome | GOTERM_CC_DIRECT |
2876 | GO:0043534 | blood vessel endothelial cell migration | GOTERM_BP_DIRECT |
2876 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria | GOTERM_BP_DIRECT |
2876 | GO:0009410 | response to xenobiotic stimulus | GOTERM_BP_DIRECT |
2876 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | GOTERM_BP_DIRECT |
2876 | GO:1902905 | positive regulation of fibril organization | GOTERM_BP_DIRECT |
2876 | GO:0005759 | mitochondrial matrix | GOTERM_CC_DIRECT |
2876 | GO:0006749 | glutathione metabolic process | GOTERM_BP_DIRECT |
2876 | GO:0034599 | cellular response to oxidative stress | GOTERM_BP_DIRECT |
2876 | GO:0005737 | cytoplasm | GOTERM_CC_DIRECT |
2876 | GO:0007605 | sensory perception of sound | GOTERM_BP_DIRECT |
2876 | GO:0040029 | regulation of gene expression | GOTERM_BP_DIRECT |
2876 | GO:0042744 | hydrogen peroxide catabolic process | GOTERM_BP_DIRECT |
2876 | GO:0045454 | cell redox homeostasis | GOTERM_BP_DIRECT |
2876 | GO:0048741 | skeletal muscle fiber development | GOTERM_BP_DIRECT |
2876 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus | GOTERM_BP_DIRECT |
2876 | GO:0042542 | response to hydrogen peroxide | GOTERM_BP_DIRECT |
2876 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress | GOTERM_BP_DIRECT |
2876 | GO:0010332 | response to gamma radiation | GOTERM_BP_DIRECT |
2876 | GO:0045444 | fat cell differentiation | GOTERM_BP_DIRECT |
2876 | GO:0051450 | myoblast proliferation | GOTERM_BP_DIRECT |
2876 | GO:0051897 | positive regulation of protein kinase B signaling | GOTERM_BP_DIRECT |
2876 | GO:0004602 | glutathione peroxidase activity | GOTERM_MF_DIRECT |
2876 | GO:0009609 | response to symbiotic bacterium | GOTERM_BP_DIRECT |
2876 | GO:0051702 | interaction with symbiont | GOTERM_BP_DIRECT |
2876 | GO:0005739 | mitochondrion | GOTERM_CC_DIRECT |
2876 | GO:0006979 | response to oxidative stress | GOTERM_BP_DIRECT |
2876 | GO:0060047 | heart contraction | GOTERM_BP_DIRECT |
2876 | GO:0098869 | cellular oxidant detoxification | GOTERM_BP_DIRECT |
2876 | GO:0097413 | Lewy body | GOTERM_CC_DIRECT |
2876 | GO:0010269 | response to selenium ion | GOTERM_BP_DIRECT |
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
GPX1 | 2876 | Brain Ischemia | C0007786 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Osteoporosis | C0029456 | Disease or Syndrome | 0.31 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Cryptogenic Chronic Hepatitis | C0524611 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Carcinoma, Transitional Cell | C0007138 | Neoplastic Process | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Hyperthyroidism | C0020550 | Disease or Syndrome | 0.5 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Cerebral Ischemia | C0917798 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Alloxan Diabetes | C0002152 | Experimental Model of Disease | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Osteoporosis, Age-Related | C0001787 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Bladder Neoplasm | C0005695 | Neoplastic Process | 0.39 | 0.498 | 0.759 | group |
GPX1 | 2876 | Hepatitis, Chronic | C0019189 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Parkinson Disease | C0030567 | Disease or Syndrome | 0.32 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Awakening Epilepsy | C0751111 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Mammary Neoplasms, Human | C1257931 | Neoplastic Process | 0.3 | 0.498 | 0.759 | group |
GPX1 | 2876 | Hypertensive disease | C0020538 | Disease or Syndrome | 0.5 | 0.498 | 0.759 | group |
GPX1 | 2876 | Osteoporosis, Senile | C0029459 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Malignant Head and Neck Neoplasm | C0278996 | Neoplastic Process | 0.31 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Cardiomyopathy, Familial Idiopathic | C1449563 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Primary Hyperthyroidism | C3714618 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Cardiovascular Diseases | C0007222 | Disease or Syndrome | 0.34 | 0.498 | 0.759 | group |
GPX1 | 2876 | Obesity | C0028754 | Disease or Syndrome | 0.31 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Glutathione Peroxidase Deficiency, Hemolytic Anemia possibly due to | C3501647 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Malignant neoplasm of breast | C0006142 | Neoplastic Process | 0.39 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Squamous cell carcinoma | C0007137 | Neoplastic Process | 0.34 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Diabetes Mellitus, Non-Insulin-Dependent | C0011860 | Disease or Syndrome | 0.36 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Reperfusion Injury | C0035126 | Injury or Poisoning | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Aura | C0236018 | Finding | 0.3 | 0.498 | 0.759 | phenotype |
GPX1 | 2876 | Breast Carcinoma | C0678222 | Neoplastic Process | 0.4 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Mammary Neoplasms | C1458155 | Neoplastic Process | 0.34 | 0.498 | 0.759 | group |
GPX1 | 2876 | Autistic Disorder | C0004352 | Mental or Behavioral Dysfunction | 0.31 | 0.498 | 0.759 | group |
GPX1 | 2876 | Endogenous Hyperinsulinism | C1257963 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Hyperglycemia, Postprandial | C1855520 | Finding | 0.3 | 0.498 | 0.759 | phenotype |
GPX1 | 2876 | Malignant neoplasm of urinary bladder | C0005684 | Neoplastic Process | 0.37 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Diabetes Mellitus, Experimental | C0011853 | Experimental Model of Disease | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Hyperinsulinism | C0020459 | Disease or Syndrome | 0.31 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Chronic active hepatitis | C0520463 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Cancer of Head | C0751177 | Neoplastic Process | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Exogenous Hyperinsulinism | C1257964 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Lung Neoplasms | C0024121 | Neoplastic Process | 0.35 | 0.498 | 0.759 | group |
GPX1 | 2876 | Streptozotocin Diabetes | C0038433 | Experimental Model of Disease | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Cardiomyopathy, Dilated | C0007193 | Disease or Syndrome | 0.33 | 0.498 | 0.759 | group |
GPX1 | 2876 | Epilepsy | C0014544 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Fatty Liver | C0015695 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Hyperglycemia | C0020456 | Disease or Syndrome | 0.31 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Neck Neoplasms | C0027533 | Neoplastic Process | 0.3 | 0.498 | 0.759 | group |
GPX1 | 2876 | Epilepsy, Cryptogenic | C0086237 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Chronic Persistent Hepatitis | C0149519 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Cancer of Neck | C0746787 | Neoplastic Process | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Post-Traumatic Osteoporosis | C0751406 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Upper Aerodigestive Tract Neoplasms | C0887900 | Neoplastic Process | 0.3 | 0.498 | 0.759 | group |
GPX1 | 2876 | Head Neoplasms | C0018675 | Neoplastic Process | 0.3 | 0.498 | 0.759 | group |
GPX1 | 2876 | Malignant neoplasm of lung | C0242379 | Neoplastic Process | 0.38 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Head and Neck Neoplasms | C0018671 | Neoplastic Process | 0.3 | 0.498 | 0.759 | group |
GPX1 | 2876 | Compensatory Hyperinsulinemia | C1257965 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Steatohepatitis | C2711227 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Congenital anemia | C0158995 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Cytopenia | C0010828 | Pathologic Function | 0.3 | 0.498 | 0.759 | phenotype |
GPX1 | 2876 | Familial Ménière disease | C4302111 | Disease or Syndrome | 0.3 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Depressive disorder | C0011581 | Mental or Behavioral Dysfunction | 0.31 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Schizophrenia | C0036341 | Mental or Behavioral Dysfunction | 0.04 | 0.498 | 0.759 | disease |
GPX1 | 2876 | Mental Depression | C0011570 | Mental or Behavioral Dysfunction | 0.31 | 0.498 | 0.759 | disease |